Understanding Why Women Are Losing More Weight On Ozempic
New Research on Ozempic
Recent findings published in JAMA Network Open highlight how women may experience greater weight loss on Ozempic, a medication commonly utilized for weight management. In a comprehensive study involving nearly 3,500 patients, researchers assessed medical records of individuals prescribed semaglutide and liraglutide. They found that while the average weight loss for those using semaglutide was approximately 5.1% of body weight, women displayed an increased likelihood of achieving significant reductions.
Key Insights from the Study
- Women are 57% more likely to lose 10% or more of their body weight on Ozempic.
- Weight loss results can differ drastically between patients; individual responses vary.
- Hormones may influence weight loss outcomes, making Ozempic more effective for women.
What to Consider Before Treatment
If considering Ozempic, understand that eligibility typically requires a classification of obesity. Factors like insurance coverage and existing gastrointestinal conditions should also be evaluated.
Consult with healthcare professionals to ensure that these medications can be part of a broader strategy that includes lifestyle changes for long-term success.
Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.